BYOMass Company

BYOMass is developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses.


Investors

Founded Date: 2017
Last Funding Type: Venture - Series Unknown
Headquarters: Sudbury, Massachusetts, United States
Investors Number: 1
Technology: Geroscience
Employee Number: 1-10
Industry: Biotechnology
Last Funding Date: 2019
Number Of Exists: Venture - Series Unknown
Investor Type: Company
Total Funding: 1500000